Edgewise Therapeutics Ownership | Who Owns Edgewise Therapeutics?

Edgewise Therapeutics Ownership Summary

Edgewise Therapeutics is owned by 32.91% institutional investors, 0.45% insiders, and 66.64% retail investors. Orbimed advisors is the largest institutional shareholder, holding 15.08% of EWTX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.67% of its assets in Edgewise Therapeutics shares.

EWTX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Edgewise Therapeutics	32.91%	0.45%	66.64%
Sector	Healthcare Stocks	232.80%	10.63%	-143.43%
Industry	Biotech Stocks	379.48%	10.37%	-289.85%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Orbimed advisors	15.52M	15.08%	$488.83M
Ra capital management	10.43M	10.13%	$328.50M
Paradigm biocapital advisors lp	7.37M	7.16%	$232.00M
Blackrock	6.02M	6.87%	$108.34M
Baker bros. advisors lp	6.58M	6.39%	$207.14M
Blackrock funding, inc. /de	6.47M	6.29%	$203.90M
Janus henderson group	5.92M	5.75%	$186.29M
Novo	5.35M	5.20%	$168.53M
Vanguard group	4.87M	4.62%	$120.89M
Driehaus capital management	4.48M	4.35%	$141.06M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
New leaf venture partners	1.03M	38.82%	$16.71M
Novo	5.35M	13.65%	$168.53M
Orbimed advisors	15.52M	9.73%	$488.83M
Cormorant asset management, lp	3.26M	5.16%	$102.69M
Paradigm biocapital advisors lp	7.37M	4.74%	$232.00M
Bioimpact capital	1.66M	4.04%	$52.31M
Siren	4.43M	3.87%	$139.55M
Ra capital management	10.43M	3.48%	$328.50M
First light asset management	1.00M	2.83%	$31.56M
Perceptive advisors	4.42M	2.73%	$139.36M

Top Buyers

Holder	Shares	% Assets	Change
Janus henderson group	5.92M	0.09%	1.35M
Blackrock	6.02M	0.00%	848.71K
Paradigm biocapital advisors lp	7.37M	4.74%	823.83K
Norges bank	751.36K	0.00%	751.36K
Alliancebernstein	1.72M	0.01%	686.00K

Top Sellers

Holder	Shares	% Assets	Change
Braidwell lp	2.35M	2.47%	-2.86M
Tcg crossover management	-	-	-2.11M
Deep track capital, lp	-	-	-1.40M
Frazier life sciences management	-	-	-1.27M
Ecor1 capital	-	-	-1.25M

New Positions

Holder	Shares	% Assets	Change	Value
Norges bank	751.36K	0.00%	751.36K	$18.64M
Vanguard fiduciary trust	521.73K	0.00%	521.73K	$16.43M
Peregrine capital management	208.67K	0.24%	208.67K	$6.57M
Freestone grove partners lp	148.43K	0.03%	148.43K	$4.68M
Macquarie management	67.41K	0.00%	67.41K	$2.12M

Sold Out

Holder	Change
American national bank	-2.00
Clearstead advisors	-4.00
Creekmur asset management	-8.00
Nelson, van denburg & campbell wealth management group	-8.00
Newedge advisors	-9.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	109	-39.11%	34,717,234	-68.99%	32	0.29%	62	-23.46%	26	-57.38%
Sep 30, 2025	176	1.15%	111,963,848	-3.66%	106	0.87%	78	-31.58%	61	60.53%
Jun 30, 2025	182	-15.35%	118,716,112	13.87%	113	0.94%	118	13.46%	39	-40.00%
Mar 31, 2025	214	1.42%	105,276,596	6.36%	110	0.99%	104	-14.05%	63	5.00%
Dec 31, 2024	67	-64.55%	17,838,374	-82.39%	19	0.16%	35	-68.75%	20	-53.49%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	2.87M	2.67%	18.86K
Vanguard US Total Market Shares ETF	2.54M	2.67%	-5.23K
BB Biotech AG Ord	2.78M	2.62%	-
iShares Russell 2000 ETF	1.59M	1.47%	13.35K
Fidelity Small Cap Growth	983.35K	1.05%	-284.60K
Polar Capital Biotech S Inc	975.00K	0.93%	-
Artisan Non-U.S. Small-Mid Growth Comp	914.19K	0.87%	281.23K
Artisan International Small-Mid Investor	914.19K	0.87%	281.23K
American Century Small Cap Growth Inv	856.21K	0.80%	-17.10K
American Century U.S. Small Cap Growth	856.21K	0.80%	-17.10K

Recent Insider Transactions

Date	Name	Role	Activity	Value
May 04, 2026	Donovan Joanne M.	CMO	Sell	$163.66K
May 05, 2026	Donovan Joanne M.	CMO	Sell	$1.93M
Apr 01, 2026	Donovan Joanne M.	CMO	Sell	$926.10K
Mar 31, 2026	Donovan Joanne M.	CMO	Sell	$685.31K
Mar 27, 2026	Donovan Joanne M.	CMO	Sell	$298.10K

Insider Transactions Trends

Date	Buy	Sell
2026 Q2	-	3
2026 Q1	-	8
2025 Q4	1	1
2025 Q3	-	7
2025 Q2	4	6

EWTX Ownership FAQ

Who Owns Edgewise Therapeutics?

Edgewise Therapeutics shareholders are primarily institutional investors at 32.91%, followed by 0.45% insiders and 66.64% retail investors. The average institutional ownership in Edgewise Therapeutics's industry, Biotech Stocks , is 379.48%, which Edgewise Therapeutics falls below.

Who owns the most shares of Edgewise Therapeutics?

Edgewise Therapeutics’s largest shareholders are Orbimed advisors (15.52M shares, 15.08%), Ra capital management (10.43M shares, 10.13%), and Paradigm biocapital advisors lp (7.37M shares, 7.16%). Together, they hold 32.36% of Edgewise Therapeutics’s total shares outstanding.

Does Blackrock own Edgewise Therapeutics?

Yes, BlackRock owns 6.87% of Edgewise Therapeutics, totaling 6.02M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 108.34M$. In the last quarter, BlackRock increased its holdings by 848.7K shares, a 16.43% change.

Who is Edgewise Therapeutics’s biggest shareholder by percentage of total assets invested?

New leaf venture partners is Edgewise Therapeutics’s biggest shareholder by percentage of total assets invested, with 38.82% of its assets in 1.03M Edgewise Therapeutics shares, valued at 16.71M$.

Who is the top mutual fund holder of Edgewise Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Edgewise Therapeutics shares, with 2.67% of its total shares outstanding invested in 2.87M Edgewise Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools